Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Emery

Showing results (21-30 of 140) with videos related to

Pageof 14
Sort By:
Trials|April 16, 2015
Assessing site performance in the Altair study, a multinational clinical trialNisha Berthon-Jones, Kymme Courtney-Vega, Anna Donaldson, et al.
AIDS (London, England)|August 17, 2005
The normalized inhibitory quotient of boosted protease inhibitors is predictive of viral load response in treatment-experienced HIV-1-infected individualsAlan Winston, Gill Hales, Janaki Amin, et al.
AIDS (London, England)|November 14, 2014
Comparison of central and local HIV-1 RNA quantification from two international clinical trialsJanaki Amin, Matthew G Law, Rebekah Puls, et al.
Clinical Immunology (Orlando, Fla.)|February 14, 2003
Chemokine receptor genotype and response to interleukin-2 therapy in HIV-1-infected individualsAlison Clegg, Peter Williamson, Robyn Biti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2009
Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trialAllison Martin, Mark Bloch, Janaki Amin, et al.
AIDS (London, England)|July 30, 2005
Evaluation of ultrasound for assessing facial lipoatrophy in a randomized, placebo-controlled trialDianne Carey, Handan Wand, Allison Martin, et al.
Plos One|April 1, 2014
HLA alleles association with changes in bone mineral density in HIV-1-infected adults changing treatment to tenofovir-emtricitabine or abacavir-lamivudineHila Haskelberg, Damien V Cordery, Janaki Amin, et al.
AIDS (London, England)|October 4, 2012
The influence of HLA supertype on thymidine analogue associated with low peripheral fat in HIVDamien V Cordery, Allison Martin, Janaki Amin, et al.
Plos One|April 12, 2014
Hip structural parameters over 96 weeks in HIV-infected adults switching treatment to tenofovir-emtricitabine or abacavir-lamivudineHila Haskelberg, Nicholas Pocock, Janaki Amin, et al.
Plos One|November 3, 2011
Predictors of limb fat gain in HIV positive patients following a change to tenofovir-emtricitabine or abacavir-lamivudineAllison Martin, Janaki Amin, Sean Emery, et al.
Pageof 14

Showing results (21-30 of 140) with videos related to

Sort By:
Pageof 14
Trials|April 16, 2015
Assessing site performance in the Altair study, a multinational clinical trialNisha Berthon-Jones, Kymme Courtney-Vega, Anna Donaldson, et al.
AIDS (London, England)|August 17, 2005
The normalized inhibitory quotient of boosted protease inhibitors is predictive of viral load response in treatment-experienced HIV-1-infected individualsAlan Winston, Gill Hales, Janaki Amin, et al.
AIDS (London, England)|November 14, 2014
Comparison of central and local HIV-1 RNA quantification from two international clinical trialsJanaki Amin, Matthew G Law, Rebekah Puls, et al.
Clinical Immunology (Orlando, Fla.)|February 14, 2003
Chemokine receptor genotype and response to interleukin-2 therapy in HIV-1-infected individualsAlison Clegg, Peter Williamson, Robyn Biti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2009
Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trialAllison Martin, Mark Bloch, Janaki Amin, et al.
AIDS (London, England)|July 30, 2005
Evaluation of ultrasound for assessing facial lipoatrophy in a randomized, placebo-controlled trialDianne Carey, Handan Wand, Allison Martin, et al.
Plos One|April 1, 2014
HLA alleles association with changes in bone mineral density in HIV-1-infected adults changing treatment to tenofovir-emtricitabine or abacavir-lamivudineHila Haskelberg, Damien V Cordery, Janaki Amin, et al.
AIDS (London, England)|October 4, 2012
The influence of HLA supertype on thymidine analogue associated with low peripheral fat in HIVDamien V Cordery, Allison Martin, Janaki Amin, et al.
Plos One|April 12, 2014
Hip structural parameters over 96 weeks in HIV-infected adults switching treatment to tenofovir-emtricitabine or abacavir-lamivudineHila Haskelberg, Nicholas Pocock, Janaki Amin, et al.
Plos One|November 3, 2011
Predictors of limb fat gain in HIV positive patients following a change to tenofovir-emtricitabine or abacavir-lamivudineAllison Martin, Janaki Amin, Sean Emery, et al.
Pageof 14